Cell therapy is an innovative approach that offers a potential long-term solution, addressing migraines at their source and ...

The specialty practice treats sleep disorders including insomnia, sleep apnea and narcolepsy as well as migraine headaches.

A groundbreaking study finds that Atogepant, the new migraine prevention drug, offers immediate relief, reducing migraine ...

Increasingly, though, consumers are seeking out non-medical preventive and reactive solutions - and wellness brands are responding in kind. Aside from head pain, migraines can cause several other ...

Eptinezumab was approved by the United States Food and Drug Administration (FDA) for preventive treatment of migraine in adults ... to deliver new therapies and solutions to people living with ...

The triptan drugs provide effective migraine relief for many people. Nevertheless, a substantial number of migraine-affected individuals are unresponsive to triptans, and such therapy can also ...

A newly approved drug, atogepant, may start reducing migraines on the very first day of use, according to a study published ...

Four migraine experts, who have been awarded a top brain prize, say they hope the condition can be cured. Their research, over 40 years, has led to new treatments for millions of people affected ...

From 2018 to 2022, the migraine treatments market grew at a CAGR of 3%. The global migraine treatments market is expected to ...

A migraine drug that has been described as "life changing" by some patients will not be made available on the NHS outside of Scotland. Erenumab - also known by the name Aimovig - is one of the ...

“Neura has built a proven solution to provide relief for individuals experiencing headache and migraine disorders,” shares Brendon Durkin, managing director of Koch Disruptive Technologi ...